Table 5.
Univariate- and multivariate analyses for acute myocardial infarction
| Variable | Univariate | Multivariate | ||
|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | |
| Age (Continuous) | 0.978 (0.939–1.019) | 0.978 | ||
| Sex (Female vs Male) | 1.782 (0.73–4.352) | 0.205 | ||
| BMI (Continuous) | 0.974 (0.853–1.111) | 0.692 | ||
| WC (Continuous) | 0.976 (0.941–1.012) | 0.191 | ||
| HTN (Negative vs Positive) | 0.541 (0.707–4.175) | 0.232 | ||
| DM (Negative vs Positive) | 1.87 (0.745–4.696) | 0.183 | ||
| Dyslipidemia (Negative vs Positive) | 3.085 (1.253–7.598) | 0.014* | 3.971 (1.112–14.174) | 0.034* |
| Current smokers (None vs Yes) | 1.733 (0.688–4.369) | 0.244 | ||
| Statin use (None vs Yes) | 1.601 (0.581–4.413) | 0.363 | ||
| Hypertension medication (None vs Yes) | 0.543 (0.189–1.557) | 0.256 | ||
| DM medication (None vs Yes) | 1.364 (0.521–3.567) | 0.527 | ||
| VAT SUVmax (≤ 0.83 vs > 0.83) | 29.4 (8.945–96.628) | < 0.001* | 31.757 (8.765–115.055) | < 0.001* |
| VAT area (Continuous) | 1 (0.995–1.004) | 0.915 | ||
BMI, body mass index; WC, waist circumference; HTN, hypertension; DM, diabetes mellitus; SUVmax, maximum standardized uptake value; VAT, visceral adipose tissue; OR, odds ratio; and CI, confidence interval
* Statistically significant difference